PUBLISHER: IMARC | PRODUCT CODE: 1819952
PUBLISHER: IMARC | PRODUCT CODE: 1819952
The global neurorehabilitation devices market size reached USD 2.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 4.5 Billion by 2033, exhibiting a growth rate (CAGR) of 9.2% during 2025-2033.
Neurorehabilitation devices refer to the equipment used for examination of the brain and central nervous system (CNS). Some of the commonly used devices include neurorobotic systems, non-invasive brain stimulators, neuroprosthetics, brain-computer interfaces and wearable devices. These devices assist in the diagnosis and treatment of a disease, disorder or injury in the nervous system of the patient. They facilitate in re-learning motor skills and optimal recovery from neurological disorders, such as Parkinson's disease, and cardiovascular stroke. As a result, neurorehabilitation devices find extensive applications across various clinics, cognitive care and research institutes and healthcare centers.
The increasing prevalence of neurological diseases, such as multiple sclerosis, Parkinson's disease and cerebral palsy, is one of the key factors driving the market growth. Moreover, the rising geriatric population, which is more susceptible to such ailments, is providing a thrust to the growth of the market. Neurorehabilitation devices aid in deploying diversified electric signals to multiple fibers of the spinal cord for the recovery of limb movements. Additionally, various technological advancements, such as the gamification of rehabilitation activities through virtual reality (VR), robotics and artificial intelligence (AI), that aid in promoting recovery are acting as other growth-inducing factors. In line with this, the utilization of novel multi-electrode stimulation for the treatment of spinal cord injuries is also contributing to the market growth. Other factors, including rising healthcare expenditure capacities of the masses, along with extensive research and development (R&D) activities, are anticipated to drive the market further.
The competitive landscape of the industry has also been examined along with the profiles of the key players being Biometrics Ltd, Bioness Inc., Bionik Laboratories Corp, BioXtreme Ltd., Boston Scientific Corporation, Ectron Ltd, Ekso Bionics, Hocoma AG (DIH International Limited), Kinestica, Kinova Inc., Medtronic plc, Saebo Inc and Tyromotion GmbH.